Nifty
Sensex
:
:
11896.80
40544.37
23.75 (0.20%)
112.77 (0.28%)

Pharmaceuticals & Drugs - Global

Rating :
72/99  (View)

BSE: 532331 | NSE: AJANTPHARM

1574.90
32.10 (2.08%)
20-Oct-2020 | 3:31PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  1532.00
  •  1584.95
  •  1528.90
  •  1542.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  68978
  •  1086.33
  •  1759.95
  •  903.40

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 13,486.23
  • 26.93
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 13,326.66
  • 0.84%
  • 4.91

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.51%
  • 0.34%
  • 8.57%
  • FII
  • DII
  • Others
  • 7.71%
  • 11.22%
  • 1.65%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.90
  • 8.34
  • 6.78

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 22.51
  • 3.08
  • 0.75

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 24.88
  • 2.39
  • -0.07

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.16
  • 26.26
  • 22.77

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.56
  • 6.90
  • 4.67

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.97
  • 17.75
  • 15.29

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
668
612
9%
682
515
32%
651
485
34%
643
544
18%
Expenses
445
444
0%
531
388
37%
465
378
23%
465
378
23%
EBITDA
223
168
33%
151
127
19%
186
107
73%
178
166
7%
EBIDTM
14%
28%
14%
25%
29%
22%
28%
31%
Other Income
13
8
72%
57
2
3378%
15
4
232%
13
15
-13%
Interest
2
2
-9%
4
1
370%
2
0
1644%
5
0
3692%
Depreciation
28
23
23%
26
19
39%
24
19
26%
23
17
33%
PBT
207
151
36%
176
109
61%
175
93
88%
162
164
-1%
Tax
59
37
60%
47
20
130%
68
26
159%
45
38
18%
PAT
148
115
29%
129
89
45%
108
67
61%
116
125
-7%
PATM
7%
19%
7%
17%
17%
14%
18%
23%
EPS
16.93
13.13
29%
14.79
10.18
45%
12.32
7.66
61%
13.33
14.36
-7%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
2,644
2,588
2,055
2,126
1,983
1,734
1,474
1,208
931
677
499
Net Sales Growth
23%
26%
-3%
7%
14%
18%
22%
30%
37%
36%
 
Cost Of Goods Sold
9,624
538
296
317
323
317
290
284
250
188
153
Gross Profit
-6,980
2,050
1,760
1,808
1,661
1,417
1,183
924
681
489
346
GP Margin
-264%
79%
86%
85%
84%
82%
80%
76%
73%
72%
69%
Total Expenditure
1,906
1,905
1,489
1,467
1,296
1,147
968
840
706
545
409
Power & Fuel Cost
-
39
33
27
19
15
13
11
10
8
6
% Of Sales
-
2%
2%
1%
1%
1%
1%
1%
1%
1%
1%
Employee Cost
-
486
431
376
295
257
201
157
123
94
71
% Of Sales
-
19%
21%
18%
15%
15%
14%
13%
13%
14%
14%
Manufacturing Exp.
-
205
175
216
193
174
131
96
82
61
40
% Of Sales
-
8%
8%
10%
10%
10%
9%
8%
9%
9%
8%
General & Admin Exp.
-
159
146
132
92
66
51
47
37
34
25
% Of Sales
-
6%
7%
6%
5%
4%
3%
4%
4%
5%
5%
Selling & Distn. Exp.
-
414
321
306
271
246
234
202
170
131
91
% Of Sales
-
16%
16%
14%
14%
14%
16%
17%
18%
19%
18%
Miscellaneous Exp.
-
64
88
92
104
71
49
42
34
30
91
% Of Sales
-
2%
4%
4%
5%
4%
3%
3%
4%
4%
5%
EBITDA
738
683
566
658
687
587
505
369
224
132
90
EBITDA Margin
28%
26%
28%
31%
35%
34%
34%
31%
24%
19%
18%
Other Income
98
92
21
24
24
21
17
14
6
6
9
Interest
12
12
1
0
1
5
6
9
19
15
18
Depreciation
101
96
72
60
61
44
52
44
34
32
25
PBT
719
668
514
623
648
559
464
330
177
91
56
Tax
218
196
127
154
141
143
146
96
65
14
6
Tax Rate
30%
30%
25%
25%
22%
26%
32%
29%
37%
15%
10%
PAT
501
468
387
469
507
416
310
234
112
77
51
PAT before Minority Interest
501
468
387
469
507
416
310
234
112
77
51
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
PAT Margin
19%
18%
19%
22%
26%
24%
21%
19%
12%
11%
10%
PAT Growth
27%
21%
-17%
-8%
22%
34%
32%
109%
45%
52%
 
EPS
57.37
53.57
44.33
53.68
58.06
47.61
35.49
26.79
12.84
8.85
5.81

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
2,599
2,245
2,041
1,568
1,191
841
593
393
298
229
Share Capital
18
18
18
18
18
18
18
12
12
12
Total Reserves
2,581
2,227
2,022
1,550
1,173
823
575
381
286
217
Non-Current Liabilities
228
42
39
9
29
56
81
102
101
76
Secured Loans
1
1
1
1
6
23
42
58
62
48
Unsecured Loans
0
0
0
0
9
10
11
16
14
11
Long Term Provisions
155
13
13
5
3
5
3
3
5
3
Current Liabilities
746
378
346
247
260
250
275
222
250
218
Trade Payables
362
225
250
178
146
109
125
132
101
71
Other Current Liabilities
180
94
64
46
57
58
48
19
43
30
Short Term Borrowings
43
33
0
0
46
18
61
51
95
109
Short Term Provisions
160
25
32
22
11
64
43
20
10
8
Total Liabilities
3,572
2,664
2,426
1,823
1,479
1,146
949
718
649
522
Net Block
1,463
1,179
1,053
589
451
288
279
273
246
214
Gross Block
1,965
1,610
1,417
895
716
550
492
438
378
313
Accumulated Depreciation
502
432
365
306
265
262
213
166
132
99
Non Current Assets
1,791
1,483
1,202
973
716
513
429
349
309
277
Capital Work in Progress
132
261
61
254
199
170
94
12
3
17
Non Current Investment
22
13
8
0
0
40
8
8
8
8
Long Term Loans & Adv.
168
28
77
42
21
9
39
49
51
34
Other Non Current Assets
7
3
4
2
4
5
9
7
1
3
Current Assets
1,781
1,181
1,224
851
763
633
520
369
340
246
Current Investments
67
65
182
182
77
19
55
0
0
0
Inventories
496
436
351
211
205
159
155
148
168
113
Sundry Debtors
775
459
460
323
372
259
202
150
141
104
Cash & Bank
205
101
93
70
43
137
60
46
11
12
Other Current Assets
238
98
115
9
66
59
47
25
19
17
Short Term Loans & Adv.
169
23
23
56
59
47
44
21
16
14
Net Current Assets
1,036
804
878
604
503
384
245
147
89
28
Total Assets
3,572
2,664
2,426
1,823
1,479
1,146
949
718
649
522

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
457
375
281
609
326
279
212
234
70
95
PBT
664
514
623
648
559
456
330
164
91
56
Adjustment
71
69
52
86
53
51
51
65
51
43
Changes in Working Capital
-123
-90
-254
26
-124
-82
-75
39
-55
6
Cash after chg. in Working capital
612
493
421
760
488
426
306
267
88
105
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-155
-118
-140
-151
-161
-146
-94
-33
-17
-10
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-224
-223
-256
-383
-209
-158
-188
-104
-53
-51
Net Fixed Assets
-214
-392
-327
-235
-197
-138
-121
-69
-46
-39
Net Investments
-12
118
-2
-105
-17
2
-60
-2
0
0
Others
2
52
73
-43
5
-23
-7
-33
-7
-12
Cash from Financing Activity
-129
-147
0
-202
-117
-105
-20
-104
-13
-56
Net Cash Inflow / Outflow
104
5
25
24
0
16
4
26
4
-11
Opening Cash & Equivalents
95
91
66
41
42
39
34
8
4
15
Closing Cash & Equivalent
199
95
91
66
41
54
39
34
8
4

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
298
257
232
178
135
96
67
45
34
26
ROA
14%
15%
22%
31%
32%
30%
28%
16%
13%
10%
ROE
19%
18%
26%
37%
41%
43%
47%
32%
29%
25%
ROCE
27%
24%
34%
46%
52%
56%
55%
39%
23%
18%
Fixed Asset Turnover
1.46
1.36
1.84
2.49
2.76
2.85
2.61
2.29
1.98
1.81
Receivable days
87
82
67
63
66
57
53
57
65
73
Inventory Days
66
70
48
38
38
39
45
61
75
84
Payable days
60
63
57
50
42
46
59
62
60
68
Cash Conversion Cycle
93
88
58
51
62
49
39
56
80
89
Total Debt/Equity
0.02
0.02
0.00
0.00
0.07
0.09
0.22
0.32
0.67
0.83
Interest Cover
57
444
1,519
478
115
78
39
10
7
4

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.